DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sectral (Acebutolol) - Hyperkalaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hyperkalaemia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sectral (Acebutolol) where reactions include hyperkalaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Sectral side effects in 89 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-01

Patient: 89 year old female

Reactions: Malaise, Renal Failure, Hyperkalaemia, Diarrhoea, Atrioventricular Block Complete, Sinoatrial Block

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aceon
    Dosage: 5 mg, qd, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-01

Sectral
    Dosage: 200 mq, qd, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-01-01
    End date: 2012-03-03

Other drugs received by patient: Lasix; Allopurinol; Levothyroxine Sodium; Omeprazole; Sintrom



Possible Sectral side effects in 88 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-10

Patient: 88 year old male

Reactions: Malaise, Hyperkalaemia, Hyponatraemia, Cognitive Disorder, Bradycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sectral
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-10-01

Nexium
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Start date: 2005-01-01

Imovane
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Start date: 2005-01-01

Ramipril
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-01-01

Other drugs received by patient: Amlodipine Besylate; Fenofibrate; Bromazepam; Plavix



Possible Sectral side effects in 88 year old male

Reported by a physician from France on 2011-12-16

Patient: 88 year old male

Reactions: Malaise, Hyperkalaemia, Hyponatraemia, Cognitive Disorder, Bradycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sectral
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-01-01
    End date: 2011-10-01

Ramipril
    Administration route: Oral
    Start date: 2011-10-01

Imovane
    Administration route: Oral
    Start date: 2005-01-01

Nexium
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-10-01

Nexium
    Administration route: Oral
    Start date: 2011-10-01

Ramipril
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-01-01
    End date: 2011-10-01

Other drugs received by patient: Fenofibrate; Lexomil Roche; Amlodipine Besylate; Plavix



Possible Sectral side effects in 88 year old male

Reported by a physician from France on 2011-12-01

Patient: 88 year old male

Reactions: Malaise, Hyperkalaemia, Hyponatraemia, Bradycardia, Cognitive Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nexium
    Administration route: Oral
    Start date: 2005-01-01

Ramipril
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-01-01
    End date: 2011-01-01

Imovane
    Administration route: Oral
    Start date: 2005-01-01

Sectral
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-01-01
    End date: 2011-10-01

Other drugs received by patient: Plavix; Lexomil Roche; Fenofibrate; Amlodipine Besylate



Possible Sectral side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-11-08

Patient: 71 year old female

Reactions: Confusional State, Hyperkalaemia, Electrocardiogram QRS Complex Prolonged, Dehydration, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: formu: 16mg tabs
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Aldactone
    Dosage: form: 25mg tabs
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2011-07-21

Glucophage
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-07-21

Sectral
    Dosage: form: 200mg tabs
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Other drugs received by patient: Rabeprazole Sodium; Previscan; Lasix; Calcium Carbonate; Cordarone



Possible Sectral side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-25

Patient: 71 year old female

Reactions: Confusional State, Electrocardiogram QRS Complex Prolonged, Diarrhoea, Hyperkalaemia, Dehydration, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2011-07-21

Atacand
    Dosage: 16 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Glucophage
    Dosage: 850 mg, 3x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-07-21

Sectral
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Other drugs received by patient: Calcium Carbonate; Lasix; Previscan; Rabeprazole Sodium; Cordarone



Possible Sectral side effects in female

Reported by a physician from France on 2011-10-24

Patient: female

Reactions: Electrocardiogram QRS Complex Prolonged, Hyperkalaemia, Dehydration, Renal Failure Acute

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Glucophage
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-07-21

Sectral
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Atacand
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Aldactone
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2011-07-21

Other drugs received by patient: Rabeprazole Sodium; Previscan; Lasix; Cordarone; Cacit Vitamine D3



Possible Sectral side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-20

Patient: 71 year old female

Reactions: Confusional State, Electrocardiogram QRS Complex Prolonged, Diarrhoea, Hyperkalaemia, Dehydration, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: 16 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Glucophage
    Dosage: 850 mg, 3x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-07-21

Aldactone
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2011-07-21

Sectral
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-07-21

Other drugs received by patient: Previscan; Calcium Carbonate; Rabeprazole Sodium; Cordarone; Lasix

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017